EC Number | Cloned (Comment) | Organism |
---|---|---|
2.3.1.256 | gene NAA30, DNA and amino acid sequence, analysis and comparison, alternative splicing variants NAA30_v1 (Naa30362) and NAA30_v2 (Naa30288), cloning from HeLa cells, overexpression of MBP-tagged Naa30362-V5 and Naa30288-V5 in HeLa cells | Homo sapiens |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
2.3.1.256 | additional information | identification of a splice variant of human NAA30, which encodes a truncated protein named Naa30288. DNA sequencing reveals that the 900 bp product derived from alternative splicing results in a 222 bp deletion from the 3' end of exon 1 (c.550_771del). The truncated splice variant (867 bp) is otherwise identical to NAA30. Splicing NAA30_v2 translates into a truncated isoform (p.Val184_Leu257del) consisting of 288 amino acids (Naa30288). The splice variant is abundantly present in thyroid cancer tissues and in several different human cancer cell lines. Naa30288 localizes predominantly to the nucleus, as opposed to annotated Naa30 which has a cytoplasmic localization. Naa30288 is missing elements of the GNAT fold. Full-length Naa30 acetylates the classical NatC substrate peptide MLGTG in vitro, whereas no significant NAT activity is detected for Naa3028. Naa30288 appears to be enzymatically inactive. Overexpression of full-length Naa30362 increases cell viability via inhibition of apoptosis. In contrast, Naa30288 does not exert an anti-apoptotic effect | Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
2.3.1.256 | cytoplasm | full-length Naa30 (Naa30362) | Homo sapiens | 5737 | - |
2.3.1.256 | additional information | immunohistochemic detection in subcellular fractions | Homo sapiens | - |
- |
2.3.1.256 | nucleus | alternatively spliced nuclear isoform Naa30288 | Homo sapiens | 5634 | - |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.3.1.256 | Homo sapiens | Q147X3 | full-length splicing variant Naa30362 | - |
EC Number | Purification (Comment) | Organism |
---|---|---|
2.3.1.256 | subcellular fractionation of HeLa cells and identification of splicing variants of Naa30 | Homo sapiens |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.3.1.256 | 8305C cell | - |
Homo sapiens | - |
2.3.1.256 | A-431 cell | - |
Homo sapiens | - |
2.3.1.256 | ARO cell | - |
Homo sapiens | - |
2.3.1.256 | B-CPAP cell | - |
Homo sapiens | - |
2.3.1.256 | BHT-101 cell | - |
Homo sapiens | - |
2.3.1.256 | CAL-62 cell | - |
Homo sapiens | - |
2.3.1.256 | CGTH-W1 cell | - |
Homo sapiens | - |
2.3.1.256 | FTC-133 cell | - |
Homo sapiens | - |
2.3.1.256 | HEK-293 cell | - |
Homo sapiens | - |
2.3.1.256 | HeLa-S3 cell | - |
Homo sapiens | - |
2.3.1.256 | MCF-7 cell | - |
Homo sapiens | - |
2.3.1.256 | NPA cell | - |
Homo sapiens | - |
2.3.1.256 | Nthy-ori 3-1 cell | - |
Homo sapiens | - |
2.3.1.256 | ONCO-DG1 cell | - |
Homo sapiens | - |
2.3.1.256 | peripheral blood mononuclear cell | primary | Homo sapiens | - |
2.3.1.256 | SH-SY5Y cell | - |
Homo sapiens | - |
2.3.1.256 | T-84 cell | - |
Homo sapiens | - |
2.3.1.256 | TAD-2 cell | - |
Homo sapiens | - |
2.3.1.256 | thyroid cancer cell | high level of alternatively spliced nuclear isoform Naa30288 | Homo sapiens | - |
2.3.1.256 | U-87MG cell | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.1.256 | acetyl-CoA + N-terminal-L-methionyl-L-alanyl-[PLD] | a NatF-type substrate | Homo sapiens | N-terminal-Nalpha-acetyl-L-methionyl-L-alanyl-[PLD] + CoA | - |
? | |
2.3.1.256 | acetyl-CoA + N-terminal-L-methionyl-L-leucyl-[GPE] | a NatE-type substrate | Homo sapiens | N-terminal-Nalpha-acetyl-L-methionyl-L-leucyl-[GPE] + CoA | - |
? | |
2.3.1.256 | acetyl-CoA + N-terminal-L-methionyl-L-leucyl-[GTG] | a NatC-type substrate | Homo sapiens | N-terminal-Nalpha-acetyl-L-methionyl-L-leucyl-[GTG] + CoA | - |
? | |
2.3.1.256 | additional information | full-length Naa30 acetylates a classical NatC substrate peptide in vitro, whereas no significant NAT activity is detected for Naa3028. Neither full-length Naa30 nor Naa30288 display any lysine acetyltransferase activity, and neither Naa30 isoforms have KAT activity towards histones. The SESSS, EEEIA and MDELF peptides are negative controls and represent NatA, Naa10 and NatB substrates, respectively. Poor activity with SGRGK peptide, which contains the natural 28-mer N-terminal sequence of histone H4, and represents a NatD-type substrate | Homo sapiens | ? | - |
- |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
2.3.1.256 | ? | x * 84000, recombinant MBP-tagged Naa30362, SDS-PAGE, x * 75000, recombinant MBP-Naa30288, SDS-PAGE | Homo sapiens |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.3.1.256 | N-terminal acetyltransferase Naa30 | - |
Homo sapiens |
2.3.1.256 | NAA30 | - |
Homo sapiens |
2.3.1.256 | NatC | - |
Homo sapiens |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
2.3.1.256 | 37 | - |
assay at | Homo sapiens |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
2.3.1.256 | 7.4 | - |
assay at | Homo sapiens |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
2.3.1.256 | acetyl-CoA | - |
Homo sapiens |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.3.1.256 | evolution | enzyme Naa30 belongs to the GNAT superfamily of acetyltransferases characterized by the highly conserved GNAT fold, which promotes Ac-CoA binding and substrate recognition | Homo sapiens |
2.3.1.256 | malfunction | overexpression of full-length Naa30 increases cell viability via inhibition of apoptosis. In contrast, Naa30288 does not exert an anti-apoptotic effect | Homo sapiens |
2.3.1.256 | additional information | homology structure modeling of Naa30 using the crystal structure of human Naa50 (PDB ID 3TFY) as template | Homo sapiens |
2.3.1.256 | physiological function | the NatC complex consists of the catalytic subunit Naa30 and the auxiliary subunits Naa35 and Naa38, and can potentially Nt-acetylate cytoplasmic proteins when the initiator methionine is followed by a bulky hydrophobic/amphipathic residue at position 2. Full-length enzyme Naa30362 improves cell viability and inhibits apoptosis | Homo sapiens |